GLRE
Greenlight Capital Re, Ltd.
GLRE trails on the overall score without a compensating advantage in the available component scores.
MS
Morgan Stanley
MS has the edge over GLRE overall, supported by stronger modeled upside and stronger valuation.
GLRE Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| N/A | |
| N/A |
GLRE's profitability is currently healthy, but its revenue is under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like GLRE.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
GLRE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.1x | $8.62 | -47% |
| Fair | 7.5x | $12.69 | -22% |
| Current | 9.7x | $16.36 | — |
| Expensive | 15x | $25.44 | +56% |
Historical ranges are pointers, not guarantees.
GLRE's PE is in its fair range at 9.7x.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS has the edge over GLRE in the historical PE scenario, which offers more potential upside but is not a forecast.
GLRE Forward outlook
There aren't enough analyst estimates for GLRE to show an outlook.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
GLRE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $1.69 | +$1.73 |
| Q2 2026 | $1.46 | +33% |
| Q1 2026 | $2.36 | +79% |
| Q4 2025 | $2.17 | +75% |
| Q3 2025 | -$0.04 | -102% |
| Q2 2025 | $1.10 | -46% |
| Q1 2025 | $1.32 | -58% |
| Q4 2024 | $1.24 | -50% |
GLRE has returned to profit: it earned $1.69 per share over the past year, after losing money the year before.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over GLRE on earnings, with more consistent year-over-year improvement.
GLRE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $148.3M | +1.5% |
| Q2 2026 | $137.5M | -14% |
| Q1 2026 | $189.7M | -11% |
| Q4 2025 | $210.3M | +48% |
| Q3 2025 | $146.1M | -22% |
| Q2 2025 | $160.1M | -8.4% |
| Q1 2025 | $213.3M | +11% |
| Q4 2024 | $141.8M | -8.8% |
GLRE's revenue fell from its 2025 peak and has held roughly level since: $148M last quarter, up 1.5% from the same quarter a year ago.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over GLRE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
GLRE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.9M | -84% |
| Q2 2026 | $31.4M | -54% |
| Q1 2026 | $37.2M | +259% |
| Q4 2025 | $100.2M | +239% |
| Q3 2025 | $31.2M | -25% |
| Q2 2025 | $68.4M | +201% |
| Q1 2025 | $10.4M | -42% |
| Q4 2024 | $29.5M | +33% |
GLRE has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
GLRE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +104K shares |
| 1 year | -1.6% | -548K shares |
| 3 years | -4.6% | -1.6M shares |
| 5 years | +0.9% | +283K shares |
| Available history | -8.1% | -2.9M shares |
GLRE has the edge over MS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $8M |
| Q2 2026 | $14.2M |
| Q1 2026 | $5M |
| Q4 2025 | $2.8M |
| Q3 2025 | $2M |
| Q4 2024 | — |
| Q3 2024 | $7.5M |
| Q4 2023 | — |
GLRE spent $30M buying back its own shares over the past year.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has 1.6B diluted shares, down 1.5% from a year ago.
GLRE Net Leverage
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
GLRE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.0 | Neutral |
| Stochastic | 52.0 | Neutral |
GLRE's weekly RSI is 58 (neutral) and its Stochastic is 52 (neutral).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
GLRE PE vs Financial Services Sector
| Metric | GLRE | Sector median | Relative |
|---|---|---|---|
| PE | 9.7x | 13x | 26% below |
| PE % | 58 | 63 | 5 pts below |
GLRE has the edge over MS on valuation relative to its sector.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
GLRE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $15.2 | 7.8% above |
| 20 week MA | $15.6 | 4.7% above |
| 50 week MA | $15.6 | 4.7% above |
| 100 week MA | $14.5 | 13% above |
| 200 week MA | $13.1 | 25% above |
GLRE has the edge over MS on trend strength, trading above more of its moving averages.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
GLRE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.1 | $7.16 | -29% |
| 2021 | $7.16 | $7.40 | +3.4% |
| 2022 | $7.40 | $8.09 | +9.3% |
| 2023 | $8.09 | $11.4 | +41% |
| 2024 | $11.4 | $13.8 | +21% |
| 2025 | $13.8 | $14.4 | +4.3% |
| 2026 YTD | $14.4 | $16.4 | +13% |
GLRE has the edge over MS on returns for 2026, with the stronger performance.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.